poisar

Stocks · News reference

Guggenheim Maintains Buy on Cognizant Tech Solns, Lowers Price Target to $65

BenzingaJul 27, 2026, 12:50 PMBenzinga Newsdesk

Guggenheim analyst Jonathan Lee maintains Cognizant Tech Solns (NASDAQ:CTSH) with a Buy and lowers the price target from $80 to $65.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 27, 2026, 12:50 PM
Checked
Jul 27, 2026, 12:50 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. The Motley FoolAug 4, 2026, 6:05 PMPatrick Sanders

    Amazon's $13 Billion AI Bet Is Now Worth $190 Billion. Here's Why That Matters.

    Amazon's $13 billion investment in AI startup Anthropic has grown to a $190.4 billion valuation in its latest regulatory filing, representing a 14.6x gain. With Anthropic now valued at $1.2 trillion on secondary markets and having filed for an IPO, Amazon's 21% stake could be worth up to $252 billion. Additionally, Amazon has secured over $100 billion in commitments from Anthropic for AI chips and computing capacity over the next decade.

    Read original at the-motley-fool